Inhibition of tumor necrosis factor-α-induced RANTES secretion by alkaline protease in A549 cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 33, Issue 5, 2005, Pages 483-489

  Krunkosky, Thomas M ^a   Maruo, Keishi ^b   Potempa, Jan ^b   Jarrett, Carla L ^b   Travis, James ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b NONE

Author keywords

Airway epithelium; Cytokine; Pseudomonas aeruginosa; Tumor necrosis factor alpha

Indexed keywords

ALKALINE PROTEINASE; CYTOKINE; MESSENGER RNA; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

AIRWAY; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BIOTINYLATION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PURIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG ALVEOLUS EPITHELIUM; NUCLEOTIDE SEQUENCE; PNEUMONIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, BLOCKING; BACTERIAL PROTEINS; CELL MEMBRANE; CELLS, CULTURED; ENDOPEPTIDASES; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; LUNG; PSEUDOMONAS AERUGINOSA; RANTES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 27644486214     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0069OC     Document Type: Article

References (39)

1. Garau J, Gomez L. Pseudomonas aeruginosa pneumonia. Curr Opin Infect Dis 2003;16:135-143.
2. Fick RBJ. Pathogenesis of the Pseudomonas lung lesion in cystic fibrosis. Chest 1989;96:158-164.
3. Leidal KG, Munson KL, Denning GM. Small molecular weight secretory factors from Pseudomonas aeruginosa have opposite effects on IL-8 and RANTES expression by human airway eoithelial cells. Am J Respir Cell Mol Biol 2001;25:186-195.
4. Buret A, Cripps AW. The immuoevasive activities of Pseudomonas aeruginosa: relevance for cystic fibrosis. Am Rev Respir Dis 1993;148:793-805.
5. Suter S. The role of bacterial proteases in the pathogenesis of cystic fibrosis. Am J Respir Crit Care Med 1994;150:S118-S122.
6. Parmely M, Gale A, Clabaugh M, Horvat R, Zhoul WW. Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect Immun 1990;58:3009-3014.
7. Horvat R, Parmely M. Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity. Infect Immun 1988;56:1673-1677.
8. Leidal KG, Munson KL, Johnson MC, Denning GM. Metalloproteases from Pseudomonas aeruginosa degrade human RANTES, MCP-1, and ENA-78. J Interferon Cytokine Res 2003;23:307-318.
9. Denning GM, Wollenweber LA, Railsback MA, Cox CD, Stoll L, Britigan BE. Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect Immun 1998;6:5777-5784.
10. Ermert M, Pantazis C, Duncker HR, Grimminger F, Seeger W, Ermert L. In situ localization of TNFalpha/β, TAGE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue. Cytokine 2003;22:89-100.
11. Krunkosky TM, Fischer BM, Martin LD, Jones N, Akley NJ, Adler KB. Effects of TNF-α on expression of ICAM-1 in human airway epithelial cells in vitro. Am J Respir Cell Mol Biol 2000;22:685-692.
12. Thomas PS. Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol Cell Biol 2001;79:132-140.
13. Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Showa D, Peschon JJ, Black RA. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 2000;275:14608-14614.
14. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci USA 1992;89:4845-4849.
15. Maeda H, Morihara K. Serralysin and related bacterial proteinases. Methods Enzymol 1995;248:395-418.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
17. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and multivariate methods, 2nd ed. Boston: PSW-Kent; 1988.
18. De Bentzmann S, Plotkowski C, Puchelle E. Receptors in the Pseudomonas aeruginosa adherence to injured and repairing airway epithelium. Am J Respir Crit Care Med 1996;154:S155-S162.
19. Wilson R, Dowling RB, Jackson AD. The effects of bacterial products on airway cells and their function. Am J Respir Crit Care Med 1996;154:5197-5201.
20. Berger M. Inflammatory mediators in cystic fibrosis lung disease. Allergy Asthma Proc 2002;23:19-25.
21. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2002;34:50s-59s.
22. Terada N, Maesako K, Hamano N, Ikeda T, Sai M, Yamashita T, Fukuda S, Konno A. RANTES production in nasal epithelial cells and endothelial cells. J Allergy Clin Immunol 1996;98:S230-S237.
23. Martin LD, Rochelle LG, Fischer BM, Krunkosky TM, Adler KB. Airway epithelium as an effector of inflammation: molecular regulation of secondary mediators. Eur Respir J 1997;10:2139-2146.
24. Krunkosky TM, Martin LD, Fischer BM, Voynow JA, Adler KB. Effects of TNF alpha on expression of ICAM-1 in human airway epithelial cells in vitro: oxidant-mediated pathways and transcription factors. Free Radic Biol Med 2003;35:1158-1167.
25. Strieter RM, Kunkel SL. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med 1994;4:640-651.
26. Skerrett SJ, Martin TR, Chi EY, Peschon JJ, Mohler KM, Wilson CB. Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aerugnosa. Am J Physiol 1999;27:L715-L727.
27. Schall T, Bacon K, Toy K, Goeddel D. Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347:669-671.
28. Kooguchi K, Hashimoto S, Kobayashi A, Kitamura Y, Kudoh I, Wiener-Kronish J, Sawa T. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect Immun 1998;66:3164-3169.
29. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002;296:1634-1635.
30. Kondo S, Sauder DN. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation. Eur J Immunol 1997;27:1713-1718.
31. Kuai J, Wooters J, Hall JP, Rao VR, Nickbarg E, Li B, Kishore MC, Qiu Y, Lin LL. NAK is recruited to the TNFR1 complex in a TNFa-dependent manner and promotes the production of RANTES:Identification of endogenous TNFR-interacting proteins by a proteomic approach. J Biol Chem 2004;279:53266-53271.
32. Amrani Y, Ammit AJ Jr, Panettieri RA. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis-α-induced interleukin-6 and RANTES in human airway smooth muscle cells: Role of p38 and p42/44 mitogen-activated protein kinases. Mol Pharmacol 2001;6:646-655.
33. Black RA. Tumor necrosis factor-α converting enzyme. Int J Biochem Cell Biol 2002;34:1-5.
34. Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J Clin Invest 2000;105:133-141.
35. Lunn CA, Fan X, Dalie B, Miller K, Zavodny PJ, Narula SK, Lundell D. Purification of ADAM 10 from bovine spleen as a TNFalpha convertase. FEBS Lett 1997;400:333-335.
36. English WR, Puente XS, Freije JM, Knauper V, Amour A, Merryweather A, Lopez-Otin C, Murphy G. 2000. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. J Biol Chem 2000;275:14046-14055.
37. Bladley JR, Thiru S, Pober JS. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 1995;146:27-32.
38. Jones SJ, Ledgerwood EC, Prins JB, Galbraith J, Johnson DR, Pober JS, Bradley JR. TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. J Immunol 1999;162:1042-1048.
39. Wang J, Al-Lamki RS, Zhang H, Kirkiles-Smith N, Gaeta ML, Thiru S, Pober JS, Bradley JR. Histamine antagonizes tumor necrosis factor (TNF) signaling by stimulating TNF receptor shedding from cell surface and Golgi storage pool. J Biol Chem 2003;278:21751-21760.